Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy

References

• Barile L, Vassalli G. (2017). Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther 174:63–78.
   PubMed Web of Science ®Google Scholar
• Cabral H, Kataoka K. (2014). Progress of drug-loaded polymeric micelles into clinical studies. J Control Release 190:465–76.
   PubMed Web of Science ®Google Scholar
• Dizaj SM, Barzegar-Jalali M, Zarrintan MH, et al. (2015). Calcium carbonate nanoparticles as cancer drug delivery system. Expert Opin Drug Deliv 12:1649–60.
   PubMed Web of Science ®Google Scholar
• Dizaj SM, Sharifi S, Ahmadian E, et al. (2019). An update on calcium carbonate nanoparticles as cancer drug/gene delivery system. Expert Opin Drug Deliv 16:331–45.
   PubMed Web of Science ®Google Scholar
• Dong Z, Feng L, Zhu W, et al. (2016). CaCO3 nanoparticles as an ultra-sensitive tumor-pH-responsive nanoplatform enabling real-time drug release monitoring and cancer combination therapy. Biomaterials 110:60–70.
   PubMed Web of Science ®Google Scholar
• Duan X, Li Y. (2013). Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small 9:1521–32.
   PubMed Web of Science ®Google Scholar
• Dwivedi P, Kiran S, Han S, et al. (2020). Magnetic targeting and ultrasound activation of liposome-microbubble conjugate for enhanced delivery of anticancer therapies. ACS Appl Mater Interfaces 12:23737–51.
   PubMed Web of Science ®Google Scholar
• Gao C, Liu T, Dang Y, et al. (2014). pH/Redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate. Carbohydr Polym 111:964–70.
   PubMed Web of Science ®Google Scholar
• Hao X, Gai W, Wang L, et al. (2021). 5-Boronopicolinic acid-functionalized polymeric nanoparticles for targeting drug delivery and enhanced tumor therapy. Mater Sci Eng C Mater Biol Appl 119:111553.
   PubMed Web of Science ®Google Scholar
• He X, Liu B, Xu C, et al. (2018). A multi-functional macrophage and tumor targeting gene delivery system for the regulation of macrophage polarity and reversal of cancer immunoresistance. Nanoscale 10:15578–87.
   PubMed Web of Science ®Google Scholar
• Huang G, Huang H. (2018). Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system. J Control Release 278:122–6.
   PubMed Web of Science ®Google Scholar
• Izci M, Maksoudian C, Manshian BB, et al. (2021). The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev 121:1746–803.
   PubMed Web of Science ®Google Scholar
• Jelonek K, Zajdel A, Wilczok A, et al. (2019). Dual-targeted biodegradable micelles for anticancer drug delivery. Mater Lett 241:187–9.
   Web of Science ®Google Scholar
• Kim GB, Aragon-Sanabria V, Randolph L, et al. (2020). High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma. Bioact Mater 5:624–35.
   PubMed Web of Science ®Google Scholar
• Li K, Li D, Zhao L, et al. (2020). Calcium-mineralized polypeptide nanoparticle for intracellular drug delivery in osteosarcoma chemotherapy. Bioact Mater 5:721–31.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu C, Xu L, et al. (2020). Nanoenabled intracellular calcium bursting for safe and efficient reversal of drug resistance in tumor cells. Nano Lett 20:8102–11.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun J, Huang Y, et al. (2021). Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid. Biochem Pharmacol 189:114453.
   PubMed Web of Science ®Google Scholar
• Ma W, Chen Q, Xu W, et al. (2021). Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer. Nano Res 14:846–57.
   Web of Science ®Google Scholar
• Mattheolabakis G, Milane L, Singh A, et al. (2015). Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target 23:605–18.
   PubMed Web of Science ®Google Scholar
• Mi P, Cabral H, Kataoka K. (2020). Ligand-installed nanocarriers toward precision therapy. Adv Mater 32:1902604.
   PubMed Web of Science ®Google Scholar
• Peng J, Fumoto S, Miyamoto H, et al. (2017). One-step formation of lipid–polyacrylic acid–calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin. J Drug Target 25:704–14.
   PubMed Web of Science ®Google Scholar
• Perez-Herrero E, Fernandez-Medarde A. (2015). Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79.
   PubMed Web of Science ®Google Scholar
• Ren WX, Han J, Uhm S, et al. (2015). Recent development of biotin conjugation in biological imaging, sensing, and target delivery. Chem Commun 51:10403–18.
   PubMed Web of Science ®Google Scholar
• Segura T, Anderson BC, Chung PH, et al. (2005). Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 26:359–71.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37.
   PubMed Web of Science ®Google Scholar
• Shi L, Hu F, Duan Y, et al. (2020). Hybrid nanospheres to overcome hypoxia and intrinsic oxidative resistance for enhanced photodynamic therapy. ACS Nano 14:2183–90.
   PubMed Web of Science ®Google Scholar
• Sindhwani S, Syed AM, Ngai J, et al. (2020). The entry of nanoparticles into solid tumours. Nat Mater 19:566–75.
   PubMed Web of Science ®Google Scholar
• Singh P, Pandit S, Mokkapati VRSS, et al. (2018). Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci 19:1979.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu D, Cheng Y, et al. (2015). Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity. Sci Rep 5:16125.
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5.
   PubMed Web of Science ®Google Scholar
• Vaidya AM, Sun Z, Ayat N, et al. (2019). Systemic delivery of tumor-targeting siRNA nanoparticles against an oncogenic LncRNA facilitates effective triple-negative breast cancer therapy. Bioconjug Chem 30:907–19.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang P, Chen L, et al. (2020). Engine-trailer-structured nanotrucks for efficient nano-bio interactions and bioimaging-guided drug delivery. Chem 6:1097–112.
   Web of Science ®Google Scholar
• Wu J, He X, Liu B, et al. (2017). Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance. J Mater Chem B 5:4697–704.
   PubMed Web of Science ®Google Scholar
• Xiong H, Du S, Ni J, et al. (2016). Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin. Biomaterials 94:70–83.
   PubMed Web of Science ®Google Scholar
• Xu C, He X, Peng Y, et al. (2020). Facile strategy to enhance specificity and sensitivity of molecular beacons by an aptamer-functionalized delivery vector. Anal Chem 92:2088–96.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang S, Xu C, et al. (2019). Multifunctional albumin-based delivery system generated by programmed assembly for tumor-targeted multimodal therapy and imaging. ACS Appl Mater Interfaces 11:38385–94.
   PubMed Web of Science ®Google Scholar
• Yang C, Gao M, Zhao H, et al. (2021). A dual-functional biomimetic-mineralized nanoplatform for glucose detection and therapy with cancer cells in vitro. J Mater Chem B 9:3885–91.
   PubMed Web of Science ®Google Scholar
• Yang R, Chen F, Guo J, et al. (2020). Recent advances in polymeric biomaterials-based gene delivery for cartilage repair. Bioact Mater 5:990–1003.
   PubMed Web of Science ®Google Scholar
• Yi X, Zeng W, Wang C, et al. (2021). A step-by-step multiple stimuli-responsive metal-phenolic network prodrug nanoparticles for chemotherapy. Nano Res 137:1–8.
   Google Scholar
• Yoo J, Park C, Yi G, et al. (2019). Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers 11:640–53.
   PubMed Web of Science ®Google Scholar
• Zha S, Chau H, Chau WY, et al. (2021). Dual-targeting peptide-guided approach for precision delivery and cancer monitoring by using a safe upconversion nanoplatform. Adv Sci 8:2002919.
   Web of Science ®Google Scholar
• Zhang P, Zhang L, Qin Z, et al. (2018). Genetically engineered liposome-like nanovesicles as active targeted transport platform. Adv Mater 30:1705350.
   Web of Science ®Google Scholar
• Zhang P, Zhang Y, Ding X, et al. (2020). A multistage cooperative nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy. Adv Mater 32:2000013.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhu P, He J, et al. (2020). TME-responsive polyprodrug micelles for multistage delivery of doxorubicin with improved cancer therapeutic efficacy in rodents. Adv Healthcare Mater 9:2000387.
   Web of Science ®Google Scholar
• Zhao D, Wang C, Zhuo R, et al. (2014). Modification of nanostructured calcium carbonate for efficient gene delivery. Colloids Surf B Biointerfaces 118:111–6.
   PubMed Web of Science ®Google Scholar